Cancer Research AACR Membership  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, X.
Right arrow Articles by Zuckerman, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, X.
Right arrow Articles by Zuckerman, K. S.
[Cancer Research 61, 6290-6296, August 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

An I{kappa}B{alpha} Inhibitor Causes Leukemia Cell Death through a p38 MAP Kinase-dependent, NF-{kappa}B-independent Mechanism

Xiaotang Hu1, William E. Janssen, Lynn C. Moscinski, Matthew Bryington, Alisa Dangsupa, Natalie Rezai-Zadeh, Brian A. Babbin and Kenneth S. Zuckerman

Interdisciplinary Oncology Program [X. H., W. E. J., L. C. M., M. B., A. D., N. R-Z., B. A. B., K. S. Z.] and Departments of Pathology [W. E. J., L. C. M.], Internal Medicine [K. S. Z.], and Biochemistry and Molecular Biology [K. S. Z.], University of South Florida, and the H. Lee Moffitt Cancer Center, Tampa, Florida 33612 [X. H., W. E. J., L. C. M., M. B., A. D., N. R-Z., B. A. B., K. S. Z.]

Treatment of U937 cells with an I{kappa}B{alpha} phosphorylation inhibitor, Bay 11-7085, induced a rapid phosphorylation of p38 mitogen-activated protein (MAP) kinase, significant apoptosis, extensive necrosis, and a weak phosphorylation of MAP kinase kinase. Bay 11-7085 had no effect on the basal levels of phosphorylated I{kappa}B{alpha} but completely inhibited phorbol 12-myristate 13-acetate-induced phosphorylation of I{kappa}B{alpha}. Although Bay 11-7085 prevented phorbol 12-myristate 13-acetate-induced NF-{kappa}B nuclear translocation, SN50, a specific inhibitor of nuclear translocation and function of NF-{kappa}B, did not induce any significant nuclear/DNA fragmentation, caspase 3 activation, or cell death. The p38 MAP kinase-specific inhibitor, SB203580, completely inhibited the phosphorylation of p38 MAP kinase and significantly decreased Bay 11-7085-induced apoptosis. In contrast, the MAP kinase kinase-specific inhibitor PD98059 had no effect on Bay 11-7085-induced apoptosis. Caspase-specific inhibitor, z-Val-Ala-Asp-fluoromethyl ketone prevented Bay 11-7085-induced activation of caspase 3 but was not able to block Bay 11-7085-induced phosphorylation of p38 MAP kinase. These data suggest that Bay 11-7085 induces apoptosis through a p38 MAP kinase-dependent, NF-{kappa}B-independent mechanism.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. G. Uzzo, P. L. Crispen, K. Golovine, P. Makhov, E. M. Horwitz, and V. M. Kolenko
Diverse effects of zinc on NF-{kappa}B and AP-1 transcription factors: implications for prostate cancer progression
Carcinogenesis, October 1, 2006; 27(10): 1980 - 1990.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yang, M. Bocchetta, B. Kroczynska, A. G. Elmishad, Y. Chen, Z. Liu, C. Bubici, B. T. Mossman, H. I. Pass, J. R. Testa, et al.
TNF-{alpha} inhibits asbestos-induced cytotoxicity via a NF-{kappa}B-dependent pathway, a possible mechanism for asbestos-induced oncogenesis
PNAS, July 5, 2006; 103(27): 10397 - 10402.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-T. Ling, X. Wang, D. T. Lee, P.C. Tam, S.-W. Tsao, and Y.-C. Wong
Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R)
Carcinogenesis, April 1, 2004; 25(4): 517 - 525.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. H. Ma, H. H. Yang, K. Parker, S. Manyak, J. M. Friedman, C. Altamirano, Z.-q. Wu, M. J. Borad, M. Frantzen, E. Roussos, et al.
The Proteasome Inhibitor PS-341 Markedly Enhances Sensitivity of Multiple Myeloma Tumor Cells to Chemotherapeutic Agents
Clin. Cancer Res., March 1, 2003; 9(3): 1136 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Hu, M. Bryington, A. B. Fisher, X. Liang, X. Zhang, D. Cui, I. Datta, and K. S. Zuckerman
Ubiquitin/Proteasome-dependent Degradation of D-type Cyclins Is Linked to Tumor Necrosis Factor-induced Cell Cycle Arrest
J. Biol. Chem., May 3, 2002; 277(19): 16528 - 16537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.